Aragen Life Sciences has taken another step towards going public as the contract research, development and manufacturing organization company has filed its draft red herring prospectus (DRHP) with Sebi for an initial public offering.
The public issue comprises a fresh issue of Rs 800 crore and an offer for sale (OFS), with promoters and investors selling up to 27,329,192 equity shares of face value of Rs 10 each.